TOTTORI UNIVERSITY HOSPITAL

• Head of department
  Kazuhiro Yamamoto
• Head of division
   

Our department is the only specialist education facility certified by the Japan Endocrine Society, Japan Diabetes Society, and Japan Thyroid Association in Tottori Prefecture. We provide the latest evidence-based medicine so that patients who have endocrine metabolic disease in this community can lead a peaceful life. We introduce the latest instruments such as insulin pump therapy, the continuous glucose measurement monitoring system, and ultrasound-guided inferior thyroid aspiration cytology. We encourage exchange of human resources with other facilities. We also support treatment of diabetes for patients in other departments of our hospital, support treatment of diseases such as endocrine tumor and electrolyte abnormality, and support smooth treatment of patients in other departments through the collaborative efforts of our multi-discipline diabetes medical support team.

Fields of expertise

• Educational hospitalization for diabetes utilizing clinical path and team medical care
• Medical support for perioperative and perinatal diabetes
• Insulin introduction for outpatients
• Introduction of continuous subcutaneous insulin infusion-CSII for type I diabetes patients
• Clinical application of a continuous glucose monitoring system
• Evaluation of insulin resistance of artificial pancreas
• Endocrine metabolic disease:
  Obstinate Graves' disease treatment with antithyroid drug (including indication of iodine-131 therapy, surgical treatment)
• Professional treatment of thyroid disease at pregnancy and birth
• Steroid mass therapy and radiation therapy for thyrotoxic ophthalmopathy
• Diagnosis of thyroid nodule applying ultrasound and fine-needle aspiration cytology
• Screening of endocrine disease and hospitalization program for examination applying
  critical path (primary aldosteronism, Cushing's syndrome, pheochromocytoma, adrenal incidentaloma, etc.)

Diseases of interests

• Diabetes(type 1, type 2, secondary, pregnancy diabetes)
• Endocrine metabolic disease (thyroid, parathyroid, adrenal gland, hypothalamus, pituitary, electrolyte abnormality, etc.)
• Metabolic syndrome, lifestyle-related disease prevention

Principal treatment

• Educational hospitalization for diabetes (1-week, 2-week path)
• Continuous subcutaneous insulin infusion—CSII for type I diabetes
• Indication of iodine-131 therapy for Graves' disease treatment (in collaboration with the Department of Radiation Oncology)
• Steroid mass therapy and radiation therapy for thyrotoxic ophthalmopathy
• Perioperative management of primary aldosteronism, Cushing's syndrome and pheochromocytoma
• Introduction of hormone replacement therapy for hypopituitarism
• Percutaneous ethanol injection therapy for treatment of the thyroid

Principal tests

• Continuous glucose monitoring system
• Insulin resistance test by artificial pancreas
• Evaluation of insulin secretional capacity by meal tolerance test
• Thyroid ultrasound
• Ultrasound-guided thyroid fine-needle aspiration cytology
• Various endocrine tolerance tests
• Adrenal venous sampling (in collaboration with the Department of Radiology)